Development of a Subcutaneous Formulation for Trastuzumab – Nonclinical and Clinical Bridging Approach to the Approved Intravenous Dosing Regimen - Bittner, B.; Richter, W. F.; Hourcade-Potelleret, F.; McIntyre, C.; Herting, F.; Zepeda, M. L.; Schmidt, J. (Drug Research, 2013)